(Press-News.org) Contact information: Juliette Savin
pr@riken.jp
81-080-889-52136
RIKEN
Ketamine acts as antidepressant by boosting serotonin
PET molecular imaging of the brain reveals that ketamine may act as an antidepressant by boosting serotonin activity in brain areas involved in motivation
Ketamine is a potent anesthetic employed in human and veterinary medicine, and sometimes used illegally as a recreational drug. The drug is also a promising candidate for the fast treatment of depression in patients who do not respond to other medications. New research from the RIKEN Center for Life Science Technologies in Japan demonstrates using PET imaging studies on macaque monkeys that ketamine increases the activity of serotoninergic neurons in the brain areas regulating motivation. The researchers conclude that ketamine's action on serotonin, often dubbed the "feel-good neurotransmitter", may explain its antidepressant action in humans.
The study, published today in the journal Translational Psychiatry demonstrates that Positron Emission Tomography (PET) molecular imaging studies may be useful in the diagnosis of major depressive disorder in humans, as well as the development of new antidepressants.
Ketamine has recently been shown to have an antidepressant action with short onset and long-term duration in patients suffering from treatment-resistant major depressive disorder, who do not respond to standard medications such as serotonin reuptake inhibitors, monoamine oxidase inhibitors and tricyclic antidepressants. However, the mechanisms underlying ketamine's action on the depressive brain have remained unclear.
To understand the effects of ketamine on the serotonergic system in the brain,
Dr Hajime Yamanaka and Dr Hirotaka Onoe, who has pioneered PET imaging on conscious non-human primates, together with an international team, performed a PET study on rhesus monkeys.
The team performed PET imaging studies on four rhesus monkeys with two tracer molecules related to serotonin (5-HT) that bind highly selectively to the serotonin 1B receptor 5-HT1B and the serotonin transporter SERT.
From the analysis of the 3 dimensional images generated by the PET scans, the researchers could infer that ketamine induces an increase in the binding of serotonin to its receptor 5-HT1B in the nucleus accumbens and the ventral pallidum, but a decrease in binding to its transporter SERT in these brain regions. The nucleus accumbens and the ventral pallidum are brain regions associated with motivation and both have been shown to be involved in depression.
In addition, the researchers demonstrate that treatment with NBQX, a drug known to block the anti-depressive effect of ketamine in rodents by selectively blocking the glutamate AMPA receptor, cancels the action of ketamine on 5-HT1B but not on SERT binding.
Taken together, these findings indicate that ketamine may act as an antidepressant by increasing the expression of postsynaptic 5-HT1B receptors, and that this process is mediated by the glutamate AMPA receptor.
###
For more information please contact:
Juliette Savin
RIKEN
Tel: +81-(0)48-462-1225
Email: pr@riken.jp
Reference:
Yamanaka et al. "A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques." Translational Psychiatry, 2013 DOI: DOI: 10.1038/tp.2013.112
About RIKEN
RIKEN is Japan's flagship research institute for basic and applied research. Over 2500 papers by RIKEN researchers are published every year in reputable scientific and technology journals, covering topics ranging across a broad spectrum of disciplines including physics, chemistry, biology, medical science and engineering. RIKEN's advanced research environment and strong emphasis on interdisciplinary collaboration and globalization has earned an unparalleled reputation for scientific excellence in Japan and around the world.
About the Center for Life Science technologies
The RIKEN Center for Life Science Technologies aims to develop key technologies for breakthroughs in the medical and pharmaceutical applications of life science as well as conduct ground-breaking research and development for the next-generation life sciences.
Ketamine acts as antidepressant by boosting serotonin
PET molecular imaging of the brain reveals that ketamine may act as an antidepressant by boosting serotonin activity in brain areas involved in motivation
2014-01-07
ELSE PRESS RELEASES FROM THIS DATE:
U of Maryland undergraduates discover rare eclipsing double asteroid
2014-01-07
U of Maryland undergraduates discover rare eclipsing double asteroid
Fewer than 100 such asteroids have been found in main asteroid belt
COLLEGE PARK, MD – Students in a University of Maryland undergraduate astronomy class have made a rare discovery that wowed professional ...
Ancient sharks reared young in prehistoric river-delta nursery
2014-01-07
Ancient sharks reared young in prehistoric river-delta nursery
ANN ARBOR—Like salmon in reverse, long-snouted Bandringa sharks migrated downstream from freshwater swamps to a tropical coastline to spawn 310 million years ago, leaving behind fossil evidence of one of ...
How you practice matters for learning a skill quickly
2014-01-07
How you practice matters for learning a skill quickly
Practice alone doesn't make perfect, but learning can be optimized if you practice in the right way, according to new research based on online gaming data from more than 850,000 people.
The ...
Ants shape their thoraces to match the tasks they perform
2014-01-07
Ants shape their thoraces to match the tasks they perform
This news release is available in Portuguese.
It was now discovered that the specialization of queen and worker ants goes beyond the presence or absence of wings. In a study published ...
Racism may accelerate aging in African-American men
2014-01-07
Racism may accelerate aging in African-American men
UMD-led study is first to link racism-related factors and cellular age
A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting ...
NYSCF scientists make living brain cells from Alzheimer's patients biobanked brain tissue
2014-01-07
NYSCF scientists make living brain cells from Alzheimer's patients biobanked brain tissue
New study shows ability to make living human cells from biobanked brain tissue
NEW YORK, NY (January 7, 2014) – Scientists at The New York Stem Cell Foundation (NYSCF) Research ...
Some brain regions retain enhanced ability to make new connections
2014-01-07
Some brain regions retain enhanced ability to make new connections
In adults, some brain regions retain a "childlike" ability to establish new connections, potentially contributing to our ability to learn new skills and form new memories as we age, ...
Several forms of vitamin E protect against memory disorders
2014-01-07
Several forms of vitamin E protect against memory disorders
Elderly people with high serum vitamin E levels are less likely to suffer from memory disorders than their peers with lower levels, according to a study published recently in Experimental ...
Patterns of social interaction remain consistent over time
2014-01-07
Patterns of social interaction remain consistent over time
The research was conducted by researchers form Aalto University and University of Oxford, and was published in Proceedings of the National Academy of Sciences of the United States of America (PNAS) recently.
"We ...
The power of packaging in consumer choices
2014-01-07
The power of packaging in consumer choices
Researchers from the University of Miami and California Institute of Technology show how the brain considers both visual cues and taste preferences when making everyday food choices
CORAL GABLES, FL (January 6, 2014) — ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Ketamine acts as antidepressant by boosting serotoninPET molecular imaging of the brain reveals that ketamine may act as an antidepressant by boosting serotonin activity in brain areas involved in motivation